Skip to content

Author

Wen Sun

We have 5 of 92 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

A photoimmune synergizing RNA interference technology for highly effective antitumor treatment

Abstract Photoimmunotherapy and RNA interference (RNAi) hold great potential for tumor therapy but exhibit limited efficacy as monotherapies. In this work, we report a red‐light‐activated combinatorial therapy that integrates photodynamic immunotherapy (PIT) with RNAi via a rationally designed photosensitizer, FNBS, de...

Xiang Xia, Bing-Bing Wu, Xue-Ze Zhao et al. · 0 citations
Aug 2026

ROS-Scavenging Single-Component Polymeric Nanocarriers for Precision siRNA Delivery in Pulmonary Fibrosis Therapy.

Idiopathic pulmonary fibrosis (IPF) is a progressive refractory lung disorder with limited effective therapies. Although RNA interference (RNAi) holds promise for IPF treatment, current delivery systems are hampered by complex preparation, redundant components, and an inability to modulate oxidative stress, which sever...

Yuxin Yang, Hua Zhang, Jian-Jun Du et al. · 0 citations
Aug 2026

A Phototheranostic Probe Activated by β-N-Acetylhexosaminidase for Fluorescence Navigation Surgery and Photodynamic Therapy of Colorectal Cancer.

Colorectal cancer (CRC) is a highly prevalent malignancy worldwide. Early diagnosis remains challenging, and its strong propensity for metastasis is a major contributor to poor patient prognosis. Current approaches for surgical guidance and photodynamic therapy (PDT) in CRC are hindered by key limitations. Imaging tech...

Yongchang Qiao, Zhiyuan Ma, Maomao He et al. · 0 citations
Open access Jul 2026

A Triple‐Stage Precision Carbon Dot Nanogel With Cascade Activation for Spatiotemporally Controlled Chemo–Photodynamic Therapy

A triple‐stage precision nanogel platform in which carbon dots serve as organelle‑targeted delivery vehicles that achieved over 85% tumor growth inhibition with minimal systemic toxicity and offers a promising strategy to overcome key barriers in cancer therapy.

Yunxiao Zhang, Jianwei Li, Lei Yue et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.